Progressive, Iovance fall; Target, Take-Two rise
NEW YORK (AP) — Target Corp., up $12.58 to $219.01.
The retailer blew away Wall Street’s first-quarter profit and revenue forecasts.
Take-Two Interactive Software Inc., up $11.66 to $179.35.
The publisher of “Grand Theft Auto” and other video games reported strong fiscal fourth-quarter financial results.
Tesla Inc., down $14.41 to $563.46.
The electric vehicle maker’s sales in China reportedly slumped in April.
Progressive Corp., down $4.98 to $101.
The insurance company’s first-quarter profit fell short of Wall Street forecasts.
Iovance Biotherapeutics Inc., down $10.64 to $16.33.
The biotechnology company expects to ask for regulatory approval of its lifileucel cancer therapy in the first half of 2022.
Myovant Sciences Ltd., down 77 cents to $21.83.
The FDA put a partial hold on a study for the biotechnology company’s relugolix combination tablet as a contraceptive.
Reata Pharmaceuticals Inc., up $19.72 to $102.63.
The FDA wants to meet with the biotechnology company before it files for approval of a treatment for the rare genetic disease Friedreich’s ataxia.
Eagle Materials Inc., down $8.32 to $139.25.
The construction and building materials company decided not to split into two separate companies.